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Although mesenchymal stem cells (MSCs) are the natural source for bone regeneration, the exact mechanisms governing MSC
crosstalk with collagen I have not yet been uncovered. Cell adhesion to collagen I is mostly mediated by three integrin receptors
– a1b1, a2b1 and a11b1. Using human MSC (hMSC), we show that a11 subunit exhibited the highest basal expression levels but
on osteogenic stimulation, both a2 and a11 integrins were signiﬁcantly upregulated. To elucidate the possible roles of collagen-
binding integrins, we applied short hairpin RNA (shRNA)-mediated knockdown in hMSC and found that a2o ra11 deﬁciency, but
not a1, results in a tremendous reduction of hMSC numbers owing to mitochondrial leakage accompanied by Bcl-2-associated X
protein upregulation. In order to clarify the signaling conveyed by the collagen-binding integrins in hMSC, we analyzed the
activationoffocaladhesionkinase,extracellularsignal-regulatedproteinkinaseandserine/threonineproteinkinaseB(PKB/Akt)
kinases and detected signiﬁcantly reduced Akt phosphorylation only in a2- and a11-shRNA hMSC. Finally, experiments with
hMSC from osteoporotic patients revealed a signiﬁcant downregulation of a2 integrin concomitant with an augmented
mitochondrial permeability. In conclusion, our study describes for the ﬁrst time that disturbance of a2b1- or a11b1-mediated
interactions to collagen I results in the cell death of MSCs and urges for further investigations examining the impact of MSCs in
bone conditions with abnormal collagen I.
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Mesenchymal stem cells (MSCs), derived from bone marrow,
have been shown to differentiate into the osteoblast lineage
in vitro as well as in vivo.
1 As a result of this ability, these cells
areconsideredtobethemaincellularplayersintheprocesses
of bone regeneration and healing. In order to survive, amplify
or differentiate into cells with a specialized function, MSC
have to establish appropriate contacts with the extracellular
matrix (ECM) in the bone marrow, which is mainly composed
of collagen type I, IV and ﬁbronectin.
2 One of the most
important and ubiquitous receptor families mediating cell–
ECM interactions is the integrin family. In vertebrates, there
exist 18 a- and 8 b-integrin subunits that can assemble into 24
different heterodimers.
3,4 Generally, the amount of a-subunit
determines the amount of receptor that will go to the cell
surface as no free a-o rb-integrin can be present on the
plasmalemma.
5 On the basis of the ligand-binding properties,
the integrins can be grouped into subgroups as the collagen
I-binding group consists of three receptors – a1b1, a2b1 and
a11b1.
5
Integrins do not only establish cell bonds with a range
of ligands but also regulate cytoskeletal dynamics and
initiate various signals that are essential for the regulation of
cellular processes, such as cell adhesion, migration and
differentiation.
6,7 Integrin signaling is initiated at the focal
adhesion sites, which are membrane-associated platforms
consisting of clustered, ECM-bound integrins as well as
various enzymes (e.g., focal adhesion kinase, FAK), cytoske-
letal and adaptor proteins (e.g., paxillin, p130
cas) in the
cytoplasm. Integrin adhesion triggers ‘outside-in’ signaling,
which frequently synergizes with growth factor-dependent
cascades and activates downstream proteins such as
extracellular signal-regulated protein kinases 1 and 2 (Erk1/2).
Furthermore, integrin-mediated anchorage and signaling can
also regulate cell survival processes and prevent cells
entering anoikis,whichisaspecial formofapoptosistriggered
by inappropriate cell–ECM interactions.
8,9 For instance, the
integrin-dependent adhesion of mammary and intestinal
epithelial cells to the ECM is pivotal to avert anoikis through
the activation of protein kinase B (PKB/Akt) survival pathway
and the prevention of mitochondrial translocation of the pro-
apoptotic protein Bcl-2-associated X protein (Bax).
10–12
Although collagen I is one of the major proteins in the bone
marrow, the precise roles of collagen-binding integrin recep-
tors in human MSC (hMSC) behavior have not been
investigated. In this study, we addressed the functions of
a1b1, a2b1 and a11b1 integrins in hMSC by applying short
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corresponding a-subunits and performing all functional
analysis on native human collagen type I. Our major ﬁnding
was that the deﬁciency of a2o ra11 integrin in hMSC leads to
initiationofcellapoptosisviaAktpathway,whilethedeﬁciency
of a1 integrin was entirely permissible for hMSC survival on
collagen I. Furthermore, a2- and a11-shRNA hMSC comple-
tely failed to osteogenically differentiate because of the
profound loss of cells throughout in vitro osteogenic stimula-
tion(OS). Finally, a pilot investigation with hMSC derivedfrom
osteoporotic patients showed a signiﬁcant downregulation of
a2 integrin in these cells. Taken together, our study reports for
the ﬁrst time that two of the collagen I-binding integrins, a2b1
anda11b1,transmitessentialandnon-redundantsignalingfor
hMSCs inhabiting collagen I-rich cell niches and that
disturbance of the collagen I–integrin interactions results in
stem cell death. Hence, we believe that our ﬁndings can open
a novel way to interpret, understand and further investigate
bone conditions in which the cell access to normal collagen
I is affected.
Results
hMSC adhesion and proliferation are enhanced on
collagen I and two of the collagen I-binding integrins are
signiﬁcantly upregulated in osteogenically differentiated
hMSC. First, we investigated the effect of collagen type I on
hMSC adhesion and proliferation. For hMSC adhesion
(Figure 1a) and proliferation analysis (Figure 1b), cells were
cultivated on collagen I, ﬁbronectin, laminin I, poly-L-lysine
(PLL) or 5% milk/PBS (blotto). After 45min, hMSC attachment
to collagen I and ﬁbronectin entered an adhesion plateau
(92.6±7.2% and 98.1±2.9%, respectively) whereas the cell
adhesion to laminin I and PLL remained lower at all-time points
(Figure 1a). Similar to the adhesion data, hMSC proliferation
was signiﬁcantly higher on collagen I and ﬁbronectin
demonstrated by bromodeoxyuridine (BrdU) incorporation
assay (Figure 1b).
Next, we investigated the basal expression of a1, a2, a11 and
b1 subunits in hMSC and human osteoblasts (hOBs) by semi-
quantitative PCR (Figure 1c). Both cell types were found to
express all integrins. Quantitative PCR performed in hMSC
revealed that, among the a-subunits, a11 had the strongest
basal expression on collagen I and the a1 mRNA levels were
higher than a2 (Figure 1d). In addition, we performed western
blot analyses of hMSC, hOBand native bone tissue (Figure1e).
The signal for a1, a2 and a11 was strong in cultured hMSC and
hOB, while the freshly isolated low-afﬁnity nerve growth factor
receptor (CD271)-positive, non-cultured hMSC and human
bone tissue revealed a weaker signal. However, we demon-
strated for the ﬁrst time the protein expression of the three
collagen I-binding integrins in native hMSC, which were directly
isolated and lysed from the bone marrow.Finally, we performed
immunostaining for integrins a1, a2 and a11 in hMSC cultured
on collagen I (Figure 1f). The cells were positive for all subunits;
however, the most robust focal adhesions were observed in the
case of a11-speciﬁc staining.
In order to investigate if the collagen-binding integrin levels
are altered during hMSC commitment into OB linage, hMSC
were osteogenically stimulated. Figures 2a and b demon-
strate the osteogenic differentiation, judged by Alizarin
Red (AR) cytochemistry, and quantiﬁcation, of three hMSC
donors at day 21. The osteogenic differentiation was further
validated by semi-quantitative PCR for osteoblast-speciﬁc
genes namely, Osterix, osteocalcin and bone sialoprotein
(Figure 2c). Quantitative RT-PCR analyses of a1, a2 and a11
integrin expression revealed no changes for a1 (Figure 2d),
while a2 and a11 were signiﬁcantly upregulated on hMSC OS
(Figures 2e and f). The increase in a2 and a11 expression on
protein level was conﬁrmed by western blotting (Figure 2g).
Taken together, these ﬁndings demonstrate that ﬁrst,
collagen I promotes hMSC adhesion and proliferation;
second, among the three collagen-binding integrins, a11 has
the most pronounced basal expression; and third, when
hMSC differentiate toward OB, a2 and a11 integrins are
signiﬁcantly upregulated, thus suggesting an important role
for hMSC functions on collagen I.
Stable and efﬁcient gene KD of a1, a2 and a11 integrins
in MSC from human bone marrow. To examine the
functional role of collagen-binding integrins, we applied
small interference RNA technology. hMSC were stably
transduced with control, a1, a2o ra11 shRNAs and cells,
which had no pro-virus integration were eliminated by
antibiotic selection. RT-PCR and western blot analyses
were used to estimate the degree of integrin KD (Figure 3).
The overall efﬁciency of integrin KD was 485% in all
independent infections of each hMSC donor. Using the
quantitative RT-PCR data, we analyzed if the downregulation
of a particular integrin subunit leads to expression changes in
the other two subunits (Figures 3b–d). We found that
following integrin a1 KD, the expression levels of a2 and
a11 increased with 1.7±0.1 and 3.7±0.5-fold, respectively.
Similar changes occurred when integrin a2 was diminished
(a1 with 2.4±0.6 and a11 with 2.1±0.5-fold increase). In
contrast, the KD of integrin a11 led only to 1.7±0.1-fold
increase in a1 mRNA whereas the level of a2 remained
unchanged. These results were also apparent on protein
levels (Figure 3e).
In conclusion, a very efﬁcient and reproducible KD of a1, a2
and a11 integrins was successfully established in hMSC. In
addition, a compensatory upregulation among some of the
integrin subunits was observed.
hMSC deﬁcient for a2o ra11 integrins exhibit a clear
defect in adhesion, spreading and migration. Sub-
sequent to the establishment of integrin KD in hMSC, we
investigated for changes in their cell attachment (Figure 4a),
spreading (Supplementary Figures 2 and 4b) and migration
on collagen I (Figures 4c–e). After 120min, all control-shRNA
(con-shRNA) and 91.6±6.5% of a1-shRNA hMSC were
attached versus only 79.1±2.5% of a2-shRNA hMSC. The
lowest cell adhesion was detected in a11-shRNA hMSC as
these cells reached a maximal adhesion of just 30.1±3%.
Con- and a1-shRNA cells required approximately 30min to
fully spread while a2- and a11-shRNA hMSC exhibited a
signiﬁcantly delayed spreading. More precisely, cells with a2
and a11 KD needed 80.8±11.5min and 61.7±6.3min to
spread, respectively. Similar to the adhesion and spreading
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Cell Death and Diseasedata, the a2- and a11-shRNA hMSC had also a migratory
deﬁcit. The average path con-shRNA cells took was
171.3±31.3mm with mean velocity of 11.4±2.1mm/h
(Figure 4c). Similarly, a1-shRNA hMSC migrated to
approximately 200mm distances with 13.9±0.4mm/h of
average speed. In comparison, the migration distance and
velocity of a2- and a11-shRNA hMSC were signiﬁcantly
reduced to approximately 50% (Figures 4d and e). In
conclusion, hMSC deﬁcient for a2 and a11 integrin
receptors exhibited a reduced adhesion, delayed spreading
and lower migration velocity.
KD of a2o ra11 integrin results in a dramatic loss of
hMSC numbers and impaired osteogenic differentiation.
Throughout hMSC cultivation on collagen I, we detected a
persistent decrease in cell numbers within the population of
a2- and a11-shRNA-transduced cells (Figures 5a and b). In
contrast, the con- and a1-shRNA hMSC continuously
increased. In order to estimate the rate of cell regression,
cell quantiﬁcation was performed and the percentage of cell
gain or loss between days 0 and 14 was determined
(Figure 5b). At day 14, con- and a1-shRNA hMSC
increased with 55.8±16% and 76.3±42%, whereas
Figure 1 hMSC adhesion and proliferation on ECM proteins, and integrin expression proﬁle. (a) Quantitative adhesion assay on collagen I, ﬁbronectin, laminin I, PLL
(poly-L-lysine)andblotto(5%milk/PBS).ThehighesthMSCadhesionwastowardﬁbronectinandcollagenI.Thedatarepresenttwoindependentexperiments.(b)Proliferation
analysis. Cells were cultured for 24h in the presence of 10mM BrdU. The highest BrdU uptake was detected when hMSC were grown on collagen I. Three independent
experiments,eachconsistingoftriplicates,wereperformed(n¼9;***Po0.001;one-wayANOVA).(c)Semi-quantitativePCRanalysisofthebasalexpressionofa1,a2,a11
andb1integrininhMSCandhOB.Shownisarepresentativeexperimentofthreeindependentrepeats.(d)QuantitativePCRanalysisofcollagenI-bindingintegrinexpression
revealed that a11 is the most strongly expressed integrin subunit in hMSC cultivated on collagen I. Data consist of three independent quantitative measurements with three
donors (n¼9; ***Po0.001; one-way ANOVA). (e) Representative western blots for integrin a1, a2 and a11 in freshly isolated CD271-MNC and CD271þhMSC, cultivated
hMSC and hOB, and hBone protein extracts conﬁrmed integrin protein expression in vivo and in vitro.( f) Immunoﬂourescent stainings of a1, a2 and a11 integrins of hMSC
culturedon collagen I. Integrina11 showedthe mostpronouncedfocaladhesions(indicatedby arrows).The stainingwas reproducedtwice,bar 50mm andin theinset20mm
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Cell Death and Diseasea2- and a11-shRNA signiﬁcantly reduced to 83.3±0.5% and
73.1±12.4%, respectively of the original seeding density.
A viral infection or a presence of double-stranded RNA
within the cells can lead to an activation of interferon (IFN)
signaling, which then can result in IFN-mediated cell
apoptosis.
13 In order to exclude that the observed reduction
of a2- and a11-shRNA hMSC numbers is due to a triggered
IFN pathway, we performed semi-quantitative PCR analyses
of genes related to IFN pathway – OAS1, OAS2, retinoic acid-
inducible gene I and IFN-induced protein with tetratricopep-
tide repeats 1. hMSC stimulated with IFNb were used as a
positive control. As shown in Figure 5c, none of the tested
genes showed distinctive upregulation in the shRNA-trans-
duced hMSC.
Finally, we induced osteogenic differentiation of hMSC and
observed that con- and a1-shRNA cells were able to
differentiateintoosteoblastsindicatedbypositiveARstaining,
whereas a2- and a11-shRNA hMSC did not deposit miner-
alized matrix shown by the lack of AR staining. Instead, during
the stimulation period, a further signiﬁcant regression in the
cell numbers of both cell types was observed (Supplementary
Figure 3).
Hence, we concluded that viral treatment and shRNA
transduction in hMSC had no stimulatory effect on IFN
pathway and that only the gene KD of a2 and a11 integrins
leads to a remarkable reduction of hMSC numbers during
cultivation as well as OS.
hMSC deﬁcient for a2o ra11 integrins exhibit a
mitochondrial permeability, BAX upregulation and
reduced activation of Akt. The observed decline in a2- or
a11-shRNA KD hMSC numbers suggested a survival defect
on collagen I; therefore apoptosis was evaluated ﬁrst by
5,50,6,60-tetrachloro-1,10,3,30-tetraethylbenzimidazolylcarbo-
cyanine iodide (JC-1) staining (Figure 6). In viable cells, JC-1
aggregates in the intact mitochondria and produces red
ﬂuorescent signal (Figure 6a). In apoptotic cells, which have
a mitochondrial leakage, JC-1 resides in the cytoplasm
in a monomeric form and stains the cell cytoplasm in green
(Figure 6b). Our results showed that con- and a1-shRNA
hMSC populations consisted of mostly non-apoptotic
cells (Figures 6c and d). In contrast, a2- and a11-shRNA
hMSC, similarly to the positive control (hMSC treated
with CD95 death receptor (FAS) antibody), were
predominantly stained in green indicating mitochondrial
leakage (Figures 6e and f).
Next, we carried out a western blot analysis for the pro-
apoptotic factor Bax, which is responsible for mitochondrial
Figure 2 Expression changes in collagen I-binding integrins on hMSC commitment into osteoblasts. (a) hMSC were osteogenically stimulated for 21 days and the
deposited calciﬁed matrix was visualized by AR staining. (b) AR quantiﬁcation. Experiments were performed with three donors (n¼3; ***Po0.001; unpaired t-test for each
donor). (c) RT-PCR analysis of Osterix, osteocalcin (OCN) and bone sialoprotein (BSP) demonstrated the upregulation of bone-speciﬁc genes. Shown is a representative
experiment of three independent repeats. Quantitative RT-PCR for integrin a1( d), a2( e) and a11 (f) revealed that a2 and a11 integrins signiﬁcantly upregulate on OS. Data
shown are for all donors as three independent quantitative RT-PCR measurements were performed per donor, (n¼9; *Po0.05; **Po0.01; ***Po0.001; unpaired t-test for
each donor). (g) Western blot analysis for a2 and a11 protein expression conﬁrmed the previous ﬁndings. A representative experiment of two independent western blots
is shown
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Cell Death and Diseasemembrane permeabilization.
14 A signiﬁcantly elevated Bax
expression was observed only in a2- and a11-shRNA hMSC
(Figure 7a).
Finally, we analyzed the activation of the integrin down-
stream targets FAK (Figure 7b), ERK (Figure 7c) and Akt
(Figure 7d) using phospho-speciﬁc antibodies. The pFAK
levels were signiﬁcantly reduced by approximately 50% in all
integrin-deﬁcient hMSC, whereas a slight reduction of pERK
and almost a complete loss of pAkt were detected only in
a2- and a11-KD hMSC. Thus, we concluded that the hMSC
shortfall observed after a2o ra11 KD is the consequence of
cell apoptosis because of the lack of adhesion-dependent
activation of the major survival effector – Akt.
A signiﬁcant downregulation of a2 integrin revealed in
hMSC derived from osteoporotic patients. To investigate
a hypothetic relationship between osteoporosis and integrin
dysregulation, a pilot study with hMSC derived from older
healthy (hMSC OH, n ¼ 3) and older osteoporotic donors
(hMSC OP, n ¼ 6) (Supplementary Table 1) was performed.
We analyzed the expression proﬁle of the collagen-binding
integrins in these cells and compared it with that of hMSC
from the younger healthy donors. Hence, an intriguing trend
was found: ﬁrst, a2 and a11 integrins were upregulated
during aging (Figure 8a) and second, no changes were
detected in a1 expression in hMSC OP whereas a11 was
slightly upregulated in hMSC OP (Figure 8b). Most strikingly,
a signiﬁcant, 17-fold downregulation of a2 was detected in
hMSC OP (Figure 8b) as well as a notable number of cells
exhibited a mitochondrial leakage (Figure 8c) in comparison
with hMSC OH (Figure 8b).
Discussion
In this study, we investigated the role of the collagen I-binding
integrins, a1b, a2b and a11b, in human, bone marrow-derived
MSC. We applied a stable, shRNA-based integrin silencing
and observed signiﬁcant changes only in the behavior of
hMSC deﬁcient for a2o ra11 integrin subunits. The major
cellular changes comprises (Figure 9): (i) reduced adhesion,
spreading and motility on collagen I; (ii) increased apoptosis
associated with mitochondrial leakage and Bax upregulation;
and (iii) affected integrin-mediated signaling to Akt, FAK
and ERK.
Owing to the high rates of hMSC adhesion and proliferation
on collagen I, we ﬁrst examined the expression levels of the
collagen I-binding integrins in hMSC cultivate on collagen I
and found that among the three different collagen I-binding
a-subunits, a11integrin had thehighest basalexpression. Our
study also reported for the ﬁrst time the in vivo expression of
the three a1, a2 and a11 integrins by analyzing freshly
isolated, non-cultured hMSC. Furthermore, we clearly
demonstrated that a2 and a11 integrins, but not a1, were
signiﬁcantly upregulatedon OSof hMSC. Forsteret al.
15 have
Figure 3 Gene silencing of a1, a2 and a11 integrins in hMSC. hMSC were transduced with a1-, a2- and a11-speciﬁc shRNA sequences as well as with con-shRNA.
(a) Semi-quantitative PCR demonstrated a downregulation of the three targeted integrins. Data are representative of three independent experiments. Quantitative RT-PCR
analysis for a1( b), a2( c) and a11 (d) integrins in shRNA-transduced hMSC. The analysis showed a signiﬁcant and reproducible integrin silencing in hMSC. Additionally,
a compensatory upregulation was evident between the three a-subunits. Data consist of quantitative RT-PCR measurements from three independent infections (n¼3;
*Po0.05; **Po0.01; ***Po0.001; ANOVA tested versus con-shRNA). (e) Conﬁrmation of the integrin a1, a2 and a11 KD on protein level. Shown is a representative
experiment from two independent western blots of all donors
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Cell Death and Diseasepreviously demonstrated by quantitative proteomic analysis
that the amount of collagen I, as well as a2 and a11 integrins,
increases during hMSC osteogenic differentiation. Hence,
we suggest that the elevation of a2 and a11 might be a
consequence of the changes in collagen I production in the
differentiating cells.
To investigate the role of these three receptors in hMSC,
we next performed a loss-of-function analysis. After the
Figure 4 Investigation of adhesion, spreading and migration of integrin-deﬁcient hMSC on collagen I. (a) Quantitative adhesion assay demonstrated that a2- and
a11-shRNA-transducedhMSChavereducedattachmenttocollagenIincomparisonwitha1-andcon-shRNAhMSC.Dataconsistoftwoindependentinfections;experiments
wereperformedintriplicate.(b)Timelapseanalysisof cellsspreadingon collagenIshowedsigniﬁcantdelayof hMSCdeﬁcient fora2o ra11 subunits.(c) Shownisa panelof
images representative of the migration distance taken by a single control or shRNA-transduced hMSC. Cell tracks are indicated with black arrows. Quantiﬁcation of migration
distance(d)andvelocity(e)revealedsigniﬁcantlylowermotilityof a2-anda11-shRNAhMSC.Time-lapseanalysiswasperformedaftertwoindependentinfections.Datainb,
d and e are representative of three independent movies as a total of 30 cells per type were evaluated (n¼3; **Po0.01; ***Po0.001; ANOVA tested versus con-shRNA)
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Cell Death and Diseaseaccomplishment of almost complete silencing of each integrin
subunit, we observed that only hMSC deﬁcient for a2o ra11
integrins exhibited adhesion, spreading and migration deﬁcits
on collagen I while a1-deﬁcient cells behaved similarly to
control hMSC. Changes in adhesion and migration efﬁcacy
after the loss of collagen I-binding integrins have been
described only in mouse cells derived from integrin knockout
models.
16–19 However, the phenotype of bone marrow-
derived MSC has not been investigated so far. Using
a2-knockout keratinocytes and dermal ﬁbroblasts, it was
shown that a2 integrin regulates the cell attachment and
migration on collagen I, whereas adhesion to collagen IV and
laminin I is permissive.
16,17 Popova et al.
18,19 reported a
positive effect of integrin a11 on embryonic ﬁbroblast
adhesion and spreading on collagen I. In contrast, the
investigators observed that this cell type was actually able to
migrate faster on various collagens when a11 was missing.
18
The reported discrepancy in the migratory behavior of
integrin-deﬁcient cells could be explained with the notion that
collagen-binding integrins might exert different effects on cell
adhesion and migration depending on the cell type or on the
availability of other compensatory integrin subunits. In our
studywithhumanMSC,weobservedthatintheabsenceofa2
integrin, a1 and a11 subunits were signiﬁcantly upregulated,
while only a slight increase in a1 was detected subsequent to
a11 KD. Hence, we suggest that the adhesion deﬁcit of
a2-deﬁcientcellswasnotassevere asthatofa11 because one
or both remaining integrins could have a compensatory role.
Integrins have been implicated also in the control of cell
differentiation and survival. Salasznyk et al.
20,21 demon-
strated that FAK and ERK signaling regulate the osteogenic
differentiation of hMSC on collagen I, however, in these
studies the upstream pathway or an integrin involvement was
not examined. Integrins are also known to trigger pro-survival
signals when cells interact with ECM proteins, but when such
contacts are disturbed, integrins can as well initiate cell
death.
22 It has been reported in human lung ﬁbroblasts that
the disruption of ECM–integrin b1 interactions leads to
reduced cell survival because of negatively affected FAK
and Akt signaling.
23 Several studies have also coupled
integrin signaling with Bcl-2/Bax-dependent apoptotic ma-
chinery in keratinocytes
24 and calvaria-derived ﬁbroblasts.
25
It has been shown in rat MSC
26 that transfection of integrin-
linked kinase, a downstream effector of b1 integrin, results in
Figure 5 Cell regression of hMSC after integrin KD and investigation of IFN pathway-related genes. (a) Subsequent to the antibiotic selection, cells were pictured every
24h for a period of 14 days. Shown are representative images at day 0 and 14. (b) hMSC deﬁcient for a2o ra11 integrin decrease in number during cultivation in vitro.
In contrast, a1-shRNA and con-shRNA hMSC were able to expand. In the text inset, the total cell gain or cell loss between day 0 and 14 is shown in percentage. The
experiment was performed in duplicates with two donors as the total cell number in 1.1cm
2 area was automatically counted by ImageJ software. (c) RT-PCR was performed
for OAS1, OAS2, retinoic acid-inducible gene I (RIG-I) and IFN-induced protein with tetratricopeptide repeats 1 (IFIT1), genes involved in IFN-related cell death. The PCR
results showed that none of the tested genes were upregulated after viral transduction of shRNA. Shown is a representative experiment of three independent infections.
Positive control: hMSC treated with 2 10
3U/ml IFNb for 72h
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Cell Death and Diseasereduction of the pro-apoptotic Bax levels and thus, assists the
MSC survival in hypoxic conditions. However, our study is the
ﬁrst one to demonstrate that the loss of collagen I–integrin
interactions triggers stem cell death; using hMSC, we showed
that the downregulation of a2o ra11 integrin, but not a1,
leads to induction of apoptosis. As no activation of the IFN
pathway was detected, we concluded that the observed cell
apoptosis is indeed speciﬁc to the KD of a2o ra11 integrin.
These cell populations were unable to expand in vitro.
Moreover, as a predominant fraction of adherent cells
exhibited mitochondrial leakage and a signiﬁcant elevation
of Bax protein levels, we suggest that the cell apoptosis was
initiated before cell detachment. We also detected a reduction
in the phosphorylation of FAK and ERK in the three integrin
KDs. However, the most pronounced reduction of pERK was
found in the a2- or a11-deﬁcient hMSC. Furthermore, both cell
populations showed a dramatic reduction of pAkt levels.
Finally, as a2-deﬁcient cells underwent cell death, despite the
upregulation of a1 and a11, we propose that each integrin
triggers a speciﬁc, non-dismissive downstream signaling
cascade. Further studies, however, are required to dissect
the exact signaling pathways mastered by a2 and a11
integrins in hMSC and other cell types.
A recent study reported that a11 integrin deﬁciency in mice
results in disorganized periodontal ligament, halted incisor
eruption and tooth-dependent dwarﬁsm.
19 The investigators
identiﬁed a number of apoptotic cells in the periodontal
ligaments. This tissue is highly enriched with collagen I and
a11b1 integrin is the only collagen receptor. Interestingly,
when fed with soft food, the a11 knockouts only partially
overcametheirgrowthretardation.Weproposethatthistooth-
independent growth defect might be linked to insufﬁcient
skeletal development because of MSC deﬁcit. In contrast to
a11, integrin a1 and a2 knockout mice show no gross
developmental abnormalities.
27,28 Taken together, the
relatively mild phenotypes of a1, a2 and a11 mutant mice
Figure 6 Investigation of themitochondrial integrityof integrin-deﬁcient hMSC.Representative microphotographs of hMSCcultivated on collagen I and stainedwith JC-1.
JC-1dyeaggregatesandemitsredcolorincellswithintactmitochondriasuchasnon-treatedhMSC(a),con-(c)anda1-shRNAhMSC(d)whereasapoptoticcellsarelabeled
in green as in the positive control – hMSC treated with 1mg/ml FAS antibody (b). hMSC with a2( e)o ra11 (f) KD are labeled in green indicating that their mitochondria are
permeabilized. Cytochemistry was performed twice independently with two donors
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Cell Death and Diseasesuggest that, under normal physiological conditions, there is
a functional redundancy between the individual collagen
receptors. However, in certain tissues or cell types, or under
disease-like conditions, these receptors might execute indis-
pensable functions. Therefore, our study urges further
investigation of the bone marrow niche of the single or double
knockout mice as well as on their involvement in experimental
models challenging bone development or healing.
Anotherpossibleﬁeldforfurtherinvestigationincludesbone
conditions associated with collagen I abnormalities such as
Figure 7 Investigation of cell apoptosis. (a) Western blot analysis for Bax, a pro-apoptotic marker, revealed a signiﬁcant elevation of this protein in a2- or a11-deﬁcient
hMSC (n¼3; **Po0.01; ANOVA tested versus con-shRNA). Quantiﬁcation of three independent western blot experiments is shown. (b–d) Representative western blots of
phosphorylatedandtotalFAK,ERKandAktincontrolandintegrinKDhMSC.pFAKwassigniﬁcantlyreducedinallintegrin-deﬁcienthMSCwhereasaslightreductionofpERK
and almost a complete loss of pAkt was detected only in a2- or a11-shRNA hMSC. Quantiﬁcation analyses were performed from two independent infections and western
blotting (n¼2, *Po0.05; **Po0.01; ***Po0.001; ANOVA tested versus con-shRNA)
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Cell Death and Diseaseosteogenesis imperfecta and osteoporosis. A recent study
has reported mutations causing osteogenesis imperfecta in
type I collagen, which are located in the binding sites for
integrinsandproteoglycans.
29Anotherstudyfoundinpatients
with speciﬁc collagen I polymorphism that the collagen I a1
and a2 chains were made in an aberrant ratio and suggested
that this is relevant for the onset of osteoporosis.
30 Further-
more, it has been shown that the total amount of collagen I
protein is decreased in hMSC derived from osteoporotic
patients
31 and that osteoblasts isolated from patients with
osteoporotic or osteoarthritic condition have reduced attach-
ment and spreading as well as decreased FAK activation.
32
However, several other studies have found no dramatic
changes in the hMSC proliferative and differentiation capacity
from osteoporotic patients.
33,34 One possible explanation for
this discrepancy is the variability in hMSC preparation and
validation.Onthebasisofourresultsandtheliterature,wenow
speculatethatinsuchconditions,oneadditionalfactormightbe
that the MSC population is being gradually exhausted in vivo
because of loss of ECM interactions and subsequent cell
death. Therefore, we performed a pilot analysis with hMSC
derived from osteoporosis-suffering patients and found that, in
comparison with hMSC from healthy old patients, the
osteoporotic cells have signiﬁcantly reduced mRNA levels of
a2 integrin. Importantly, further experiments involving higher
numberofpatientswillbenecessarytoclarifywhatroleintegrin
expression and signaling undertake in bone diseases. Such
studies are currently ongoing.
In conclusion, our study contains the ﬁrst cellular and
molecular analysis demonstrating the role of collagen
I-binding integrins in the survival of MSCs in collagen I-rich
environment and calls for future investigations examining the
impact of MSCs in bone conditions with abnormal collagen I.
Materials and Methods
Human cells and cell culture. The summary of hMSC donors used in this
study is shown in Supplementary Table1. hMSC were purchased from Lonza
(Basel, Switzerland) or were isolated from bone marrow by ﬁcoll gradient
centrifugation (the procedure was approved by the LMU ethical commission, grant
311–04).ThehMSCcharacteristicswereveriﬁedbytheproducerorbyusaccording
to Dominici et al.
35 Brieﬂy, hMSC were proven by FACS to be positive (498%) for
the MSC-related markers, 50-nucleotidase, GPI-linked glycoprotein and endoglin,
and negative for the hematopoietic-related markers, monocytes/macrophages
receptor, hematopoietic progenitor marker and protein tyrosine phosphatase
receptor type C and by two-lineage differentiation to be multipotent (data not
shown). hMSC were cultured in MEM Alpha GlutaMAX medium (Invitrogen,
Karlsruhe, Germany) supplemented with 10% fetal bovine serum (Sigma,
Taufkirchen, Germany) and were grown on plastic or 10mg/ml native human
collagen I-coated surfaces (BD Biosciences, San Jose, CA, USA). hMSC at
passages5–9wereusedintheexperiments.hOBswerepurchasedfromPromoCell
(Heidelberg, Germany) and maintained in OB-speciﬁc growth medium (PromoCell).
Cells were maintained at 60–80% conﬂuence in T-75 culture ﬂasks, at 371C/5%
Figure 8 Pilot investigation of the mRNA levels of collagen I-binding integrins in hMSC derived from younger healthy (n¼3), older healthy (hMSC OH, n¼3) and older
osteoporotic patients (hMSC OP, n¼6). For donor information refer to Supplementary Table 1. (a) Quantitative RT-PCR showed an upregulation of a2 and a11 integrins
during aging (young hMSC versus hMSC OH; n¼9; *Po0.05; **Po0.01; unpaired t-test for each a-integrin subunit). (b) Comparison between hMSC OH and hMSC OP
revealedthatintegrina2wassigniﬁcantlydownregulatedinhMSCOP(n¼15;**Po0.01;unpairedt-testforeacha-integrinsubunit).(c)JC-1stainingdemonstratedinhMSC
OPaprominentnumberofcellswithmitochondrialpermeabilization(green-labeledcells)incontrasttocontrolhMSC,whichhadmostlyintactmitochondria(red-labeledcells).
Photomicrographs represent three different hMSC OP donors
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Cell Death and DiseaseCO2. CD271-negative mononuclear cells (MNCs) and CD271-positive hMSC were
isolated with a CD271 MicroBead kit (Miltenyi Biotec, Bergish Gladbach, Germany)
from three human bone marrow MNC fractions (Cat. No. 2M-125C) purchased from
Lonza and immediately after the cell separation the freshly isolated cells were lysed
for protein analysis.
shRNA cloning, lentiviral production and infection of
hMSC. shRNA oligonucleotides were designed with Invitrogen’s BLOCK-iT
RNAi Designer (Invitrogen) against the human integrin a1, a2 and a11 and
b-galactosidase genes (Supplementary Table 2). Double-stranded oligonucleotides
were annealed and ligated into the pENTR/U6 vector according to the
manufacturer’s instructions (Invitrogen). The shRNA constructs were transferred
to the ﬁnal pLenti4/BlockIT-DEST expression vector by recombination using LR
Clonase (Invitrogen) and were validated by sequencing. The ﬁnal plasmids were
prepared with EndoFree Plasmid Maxi Kit (Qiagen, Hilden, Germany). For viral
production and cell infection, Invitrogen’s ViraPower lentiviral system was used.
The pLenti4/BlockIT-U6-shRNA plasmid was transfected into 293FT cells and viral
supernatant was collected after 48h. hMSC were incubated with the virus-
containing supernatant for 24h in the presence of 8mg/ml polybrene (Sigma) and
were selected with 50mg/ml Zeocin (Invitrogen) for 10 days. As the three different
donor-derived cells represented equivalent hMSC populations (Supplementary
Figure 1), we designated hMSC XI as the main donor. hMSC XI was infected
independently three times and used in all experiments. The additional two donors,
hMSC XIII and hMSC XV, were infected once and were used only in the major
experiments to conﬁrm that the observed phenotype is not donor-speciﬁc.
Semi-quantitative and real-time PCR. Total RNA was extracted with
RNeasy Mini Kit (Qiagen). For cDNA synthesis, 1mg total RNA and AMV First-
Strand cDNA Synthesis Kit (Invitrogen) were used. RT-PCR was performed with
Taq DNA Polymerase (Invitrogen) in MGResearch instrument (Bio-Rad, Munich,
Germany). Primer pairs and PCR conditions are listed in Supplementary Table 3.
For quantitative RT-PCR, LightCycler Fast Start DNA Master SYBR Green kit
(Roche, Munich, Germany) and primer kits for a1, a2, a11 and glyceraldehyde
3-phosphate dehydrogenase (GAPDH) (Search-LC, Heidelberg, Germany) were
used. The quantitative RT-PCR was performed in LightCycler1.5 instrument
(Roche) equipped with LightCycler3.5.3 software. Crossing points for each sample
were determined by the second derivative maximum method and relative
quantiﬁcation was performed using the comparative DDCt method according to
the manufacturer’s protocol. The relative gene expression was calculated as a ratio
to GAPDH. All PCR results have been reproduced minimum three times. For PCR
analysis of IFN-related gene expression, a positive control was prepared by
incubatinghMSCwith 2 10
3U/mlIFNb (Cat.No.CYT-26766, Dianova,Germany)
for 72h at 371C as demonstrated in Croitoru-Lamoury et al.
36
Western blot analysis. Adherent cells were directly lysed in 1x Laemmli
buffer (200mM Tris-HCl pH 6.8, 40% glycerol, 10% sodium dodecyl sulfate (SDS),
30% 2-mercaptoethanol, 0.02% bromphenolblue and 0.2M dithiothreitol). The
lysates were homogenized, denatured at 991C for 5min and centrifuged at 41C for
10min.Equalvolumesoftheproteinlysateswereloadedon8%or15%SDS-PAGE
gelsandtransferredontopolyvinylideneﬂuoridemembranes.Forblocking,5%skim
milk (Merck, Darmstadt, Germany) in Tris-buffered saline buffer (0.05% Tween20)
was used. The following primary anti-human antibodies were applied: integrins a1
anda11(bothR&DSystems,Minneapolis,MN,USA),integrina2(BDBiosciences),
Bax (Biolegend, San Diego, CA, USA), phospho-FAK (Invitrogen), total FAK, total
and phospho-ERK1/2, and total and phospho-Akt (all Cell Signaling, Danvers, MA,
USA). In the western blot analysis, b-actin (Santa Cruz Biotechnology, Santa Cruz,
Figure 9 Schematic model summarizing the cell phenotype of human MSC deﬁcient for integrin a2o ra11. Integrins are heterodimeric receptors (white and blue forms)
havingcentralrolesinestablishmentofcelltoextracellularmatrixinteractions(e.g.,collagentypeI,pinkshape)andinregulationofcrucialcellprocesses(arrows)byengaging
various integrin-, membrane-, actin- and signaling-associated proteins (multi-color dots). As the amount of a-subunit determines the amount of receptor present on the
plasmalemma, we applied here a lentiviral delivery of a-subunit-speciﬁc shRNA in hMSC. Thereby, highly efﬁcient and stable KD of integrin a1, a2 and a11 was achieved
(represented by the translucent a-subunit). Our functional analyses showed that only the deﬁciency of a2o ra11 integrin leads to signiﬁcant changes in hMSC behavior on
collagenI(redarrows).Mostimportantly,hMSCmaintenancewasaffectedasthesecellsdisplayedfeaturestypicalforcellapoptosis.Takentogether,thisstudyreportsforthe
ﬁrst time that disturbance of collagen I–integrin interactions results in the cell death of MSCs. The image is adapted from Docheva et al.
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the integrins on the same protein membrane. The antibodies were diluted in the
blocking solution and incubated overnight at 41C. Secondary horseradish
peroxidase-conjugated antibodies (Rockland, Gilbertsville, PA, USA or Santa
Cruz)wereapplied for1hat roomtemperature.Electrochemiluminescencesolution
(GE Healthcare, Waukesha, WI, USA) and Lumi-detection ﬁlms (Roche) were used
for protein visualization. Band intensities were quantiﬁed with ImageProPlus4
software program (Media Cybernetics, Bethesda, MA, USA).
Immunocytochemistry and cytochemistry. hMSC were cultured on
30mg/ml collagen I-coated glass slides (BD Biosciences) for 48h. The cells were
ﬁxed with methanol or acetone/methanol, treated with Image-iT FX signal enhancer
(Invitrogen) and blocked with 10% BSA. Primary antibodies against integrins a1
(R&DSystems),a2 (AbD Serotec,Oxford,UK) anda11
37 wereapplied overnightat
41C. Next, secondary Alexa Flour 488-conjugated antibodies and 40,6-diamidino-2-
phenylindolewereused(allInvitrogen).Forapoptosisanalysis,theﬂuorescentJC-1
dye(Invitrogen)wasimplicated.shRNA-transducedhMSC(2 10
3cells/cm
2)were
cultured on collagen I-coated glass slides for 24h. On the basis of Kennea et al.,
38
to create a positive control for apoptosis, hMSC were treated with 1mg/ml FAS
antibody (BD Biosciences) for 2h at 371C, followed by overnight incubation with
1mg/ml donkey anti-mouse IgG (Santa Cruz). Next, the cells were incubated with
3mg/ml JC-1 and 1mg/ml 2,50-Bi-1H-benzimidazole (both Invitrogen) solved in
complete growth medium for 30min at 371C/5% CO2. Photomicrographs were
taken with Axiocam MRm camera (Carl Zeiss, Jena, Germany) on Axioskope 2
or Axiovert100 microscope (Carl Zeiss). Staining procedures were reproduced at
least twice with hMSC XI and hMSC XIII.
Proliferation analyses. Long-term cell growth was examined by calculating
hMSC cumulative population doubling (PD) and PD time according to Docheva
et al.
39 S-phase analysis was performed with the Cell Proliferation ELISA, BrdU
(colorimetric) kit (Roche) as described in Bo ¨ker et al.
40 Brieﬂy, 96-well dishes were
coated with 10mg/ml collagen I (BD Biosciences), ﬁbronectin, laminin I and PLL (all
R&D Systems) and seeded with 3 10
3 hMSC per well. After 12h, media
supplemented with 10mM BrdU was added.BrdUincorporationwas measured after
24h using microplate reader (Microtek, Overat, Germany) at 450nm with 690nm
referencewavelength.Threeindependentexperiments wereperformed in triplicate.
For assessment of cell numbers after shRNA transduction, hMSC XI and XV were
platedinsix-welldishesandmicroscopicallyphotographedevery24hforaperiodof
14 days. Then, two differentareas per well (each 1.1cm
2) were used for automated
cell counting by ImageJ software program (http://rsb.info.nih.gov/ij).
Adhesion assay. Cell adhesion assay was performed as described in
Docheva et al.
39 In brief, 96-well plates were coated with 10mg/ml collagen I,
ﬁbronectin, laminin I and blocked with 5% milk/PBS (blotto). hMSC were plated
in triplicate (3 10
3 cells per well) and incubated for various time periods
(15–120min)at371C,thennon-adherentcellswereremovedbyPBSwashing.Cell
adhesion was colorimetrically estimated using p-nitrophenyl N-acetyl-beta-D-
glucosaminide (Sigma-Aldrich, Munich, Germany) as a substrate. Absorbance
was measured at 405nm on microtitre-plate reader (Microtek). The percentage of
adherent cells was calculated to a maximal reference (suspension of 3 10
3 cells).
Two independent experiments were performed.
Livecellimaging. Timelapseexperimentswereperformedwithanautomated
Axiovert100 inverted microscope system (Carl Zeiss) equipped with controlled
biochamber (Pecon, Erbach, Germany). hMSC (2 10
4 cells per well) were plated
on collagen I-coated six-well dishes. For spreading analysis, cells were imaged
immediately after plating with 20 frames/h for 3h using 20 ´ objective and Axiocam
MRm camera (Carl Zeiss). For migration analysis, cells were imaged 3h after
plating for 18h with 4 frames/h. Three independent movies were produced and
approximately 30 cells per type were evaluated. hMSC XI, from two independent
viral infections, were used for the time lapse-based experiments. The obtained data
were processed with AxioVision LE (Carl Zeiss) and ImageJ software programs.
Osteogenic differentiation. OS was performed as described previously in
Bo ¨ker et al.
40 Brieﬂy, hMSC were plated in six-well dishes in a density of 3.5 10
3
cells/cm
2. Osteogenic media was applied for 21 days and was changed twice
weekly. The osteogenic differentiation was evaluated by AR staining, which
visualizes calcium-rich deposits produced by the cells. AR staining and
quantiﬁcation were performed with Osteogenic Quantiﬁcation kit (Millipore,
Billerica, MA, USA) according to the manufacturer’s instructions. First, pictures
were taken on Axiovert100 microscope with AxioCam ICc3 color camera (Carl
Zeiss) and next, AR was extracted with 10% acetic acid and neutralized with 10%
NH4OH. Optical density measurements were taken at 405nm on microtitre-plate
reader (Microtek). The AR amount was calculated against an AR standard curve.
The experiment was repeated three times.
Statistics. Statistical evaluation was performed using the GraphPrism software
(GraphPad, La Jolla, CA, USA). All quantitative data were acquired from two or
three independent experiments, each performed with duplicates or triplicates.
GraphsandbarchartsshowmeanvaluesandS.D.Unpairedt-testwasusedfortwo
group analysis and Dunett’s one-way ANOVA was applied for multi group statistical
testing. A P-value o0.05 was considered statistically signiﬁcant.
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